Historical source basis: 2026-08-06.
Before treating an acquisition price as a useful reference, establish what it bought. WELL’s OID and UnionMD disclosures describe two acquisitions with different ownership stakes and one combined consideration package. About C$115m was paid at closing; the package could reach C$160m including earnouts and vendor financing. Those figures describe different parts of the same package.
The WELL group acquired all of Ontario Imaging Diagnostics, an Ontario diagnostic-imaging network, and approximately 65% of UnionMD, a Quebec healthcare platform. Both closed on June 1, 2026. The combined figures do not provide a separate price for either business. They also do not establish a common ownership percentage that can be applied to both targets. Keep the two acquisitions visible when reading the shared headline.
What the disclosed figures mean
Combined amount paid at closing
Canadian dollars: About C$115m
For both acquisitions together. This amount is included in the maximum package below; do not add the two amounts.
Maximum combined consideration
Canadian dollars: Up to C$160m
Includes the closing amount, earnouts and vendor financing. It is not all cash paid at closing.
Separate earnout amount
Canadian dollars: Not established
The read disclosures do not establish its allocation within the package or the amount eventually paid.
Separate vendor-financing amount
Canadian dollars: Not established
The split from earnouts and the associated payment dates are not established by this case.
The practical lesson is to ask for an allocation before making a comparison. Here, a package total cannot tell you the separate price paid for OID or UnionMD. Nor can the gap between closing consideration and the maximum be labelled entirely an earnout: vendor financing is also included. A useful offer summary keeps the business and stake, closing amount, and each future-payment component distinct.
Keep the dates separate
June 1, 2026 · both acquisitions closed — The later disclosures identify this as the closing date for the two acquisitions.
June 2, 2026 · issuer announcement — WELL described the different stakes and combined package. This disclosure date follows the reported closing date.
August 6, 2026 · later MD&A confirmation — The dated Q2 MD&A confirms the June acquisitions and consideration. It does not represent another acquisition.
Questions to take into your own conversation
These are DFC’s discussion prompts, not undisclosed terms of this transaction.
Which businesses and ownership stakes would my offer include, and is a price stated for each?
Which amount is payable at closing, and where is it included in the quoted total?
Can each future component be identified separately, with its amount, conditions and payment dates?
What evidence would support a proposed allocation before I use another transaction as a price reference?
What remains unknown about the amount attributable to my own interest?
What the record does not tell us
Price allocation between OID and UnionMD.
Separate earnout and vendor-financing amounts, payment dates and realized payouts.
The numerical gap between the maximum and closing amount cannot be labelled entirely an earnout.
No common stake percentage, net seller proceeds or comparable whole-company value.
Read the original disclosures
WELL Health Technologies Corp. — Q2 2026 interim management discussion and analysis — Q2 2026 MD&A, PDF page 7, Business updates, for the combined closing amount and maximum including earnouts and vendor financing. PDF page 2 establishes Canadian currency and the August 6 MD&A date.
WELL Health Technologies Corp. — June 2 guidance and acquisition announcement — June 2, 2026 issuer announcement, acquisition discussion, for the June 1 closings, different stakes and Ontario/Quebec businesses. Read the currency and package figures with the later MD&A.
Read against the named historical documents; no comprehensive later-amendment search or current buyer mandate is implied.